Detailed information about the course

[ Back ]
Title

Visit to Debiopharm

Dates

29 September 2022

Organizer(s)

Emilie Trachsel 

PhD student Dept. Microbiology & Molecular Medicine University of Geneva

Speakers
Description

Objectives:

Give the opportunity for PhD students to meet potential future employers, and understand practical aspects of the job directly on site.

Debiopharm (https://www.debiopharm.com/) is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. 50% of Debiopharm employees are former academics and Ingeneers.

Debiopharm is composed with 4 different societies:

1) Debiopharm International SA

2) Après-Demain SA

3) Debiopharm Innovation Fund SA in Lausanne

4) Debiopharm Research & Manufacturing SA in Martigny

The company propose a visit of the Research & Manufacturing SA society based in Martigny 

 

Program

Meeting at the Debiopharm lab, Martigny

  • 9h30 welcome (café-croissants) and presentation of Debiophram activities :

- Manufacture of controlled-release drugs such as: Decapeptyl®/Trelstar®/Pamorelin®, a drug for the treatment of advanced prostate cancer and certain hormone-dependent diseases in women

- Manufacture of controlled-release drugs such as: Fabiotic®, a drug for the treatment of bacterial infections)

  • 10h-11h visit (2 groups of 10)
  • 11h-11h30 Discussion and questions session
Location

Debiopharm Martigny

Information
Expenses

Travel expenses are covered by CUSO

Registration

Deadline 15.09.2022

Cancellation : before 15.09.2022

Places

20

Deadline for registration 15.09.2022
Contact

In case of question, please write to us at microbiologie(at)cuso(dot)ch

short-url short URL

short-url URL onepage